Advertisement

Index by author

May 01, 1994; Volume 45,Issue 5

A

  1. Agbotounou, W K

    1. Effects of tyrphostins on the activated c-src protein in NIH/3T3 cells.
      W K Agbotounou, A Levitzki, A Jacquemin-Sablon and J Pierre
      Molecular Pharmacology May 1994, 45 (5) 922-931;

  2. Akbar, M

    1. A single species of A1 adenosine receptor expressed in Chinese hamster ovary cells not only inhibits cAMP accumulation but also stimulates phospholipase C and arachidonate release.
      M Akbar, F Okajima, H Tomura, S Shimegi and Y Kondo
      Molecular Pharmacology May 1994, 45 (5) 1036-1042;

  3. Ali, A

    1. Protein kinase C-dependent regulation of sulfidopeptide leukotriene biosynthesis and leukotriene C4 synthase in neutrophilic HL-60 cells.
      S Kargman, A Ali, J P Vaillancourt, J F Evans and D W Nicholson
      Molecular Pharmacology May 1994, 45 (5) 1043-1049;

B

  1. Barnes, P J

    1. Characterization of [3H]Ba 679 BR, a slowly dissociating muscarinic antagonist, in human lung: radioligand binding and autoradiographic mapping.
      E B Haddad, J C Mak and P J Barnes
      Molecular Pharmacology May 1994, 45 (5) 899-907;

  2. Baron, P

    1. Elevation of glutathione levels by phase II enzyme inducers: lack of inhibition of human immunodeficiency virus type 1 replication in chronically infected monocytoid cells.
      H J Prochaska, L Rubinson, Y Yeh, P Baron and B Polsky
      Molecular Pharmacology May 1994, 45 (5) 916-921;

  3. Bell, G I

    1. Alternative splicing of human inwardly rectifying K+ channel ROMK1 mRNA.
      H Yano, L H Philipson, J L Kugler, Y Tokuyama, E M Davis, M M Le Beau, D J Nelson, G I Bell and J Takeda
      Molecular Pharmacology May 1994, 45 (5) 854-860;

  4. Berg, K A

    1. 5-Hydroxytryptamine type 2A receptors regulate cyclic AMP accumulation in a neuronal cell line by protein kinase C-dependent and calcium/calmodulin-dependent mechanisms.
      K A Berg, W P Clarke, Y Chen, B J Ebersole, R D McKay and S Maayani
      Molecular Pharmacology May 1994, 45 (5) 826-836;

  5. Binaschi, M

    1. Influence of structural modifications at the 3' and 4' positions of doxorubicin on the drug ability to trap topoisomerase II and to overcome multidrug resistance.
      G Capranico, R Supino, M Binaschi, L Capolongo, M Grandi, A Suarato and F Zunino
      Molecular Pharmacology May 1994, 45 (5) 908-915;

  6. Bischer, P

    1. Short and long term effects of cytoskeleton-disrupting drugs on cytochrome P450 Cyp1a-1 induction in murine hepatoma 1c1c7 cells: suppression by the microtubule inhibitor nocodazole.
      A Schöller, N J Hong, P Bischer and J J Reiners
      Molecular Pharmacology May 1994, 45 (5) 944-954;

  7. Bollen, A

    1. Properties and regulation of the coupling to adenylate cyclase of secretin receptors stably transfected in Chinese hamster ovary cells.
      J P Vilardaga, E Ciccarelli, C Dubeaux, P De Neef, A Bollen and P Robberecht
      Molecular Pharmacology May 1994, 45 (5) 1022-1028;

  8. Bombien, E

    1. Transfected muscarinic acetylcholine receptors selectively couple to Gi-type G proteins and Gq/11.
      S Offermanns, T Wieland, D Homann, J Sandmann, E Bombien, K Spicher, G Schultz and K H Jakobs
      Molecular Pharmacology May 1994, 45 (5) 890-898;

  9. Bürki, E

    1. Signal transduction by the cloned glucagon-like peptide-1 receptor: comparison with signaling by the endogenous receptors of beta cell lines.
      C Widmann, E Bürki, W Dolci and B Thorens
      Molecular Pharmacology May 1994, 45 (5) 1029-1035;

C

  1. Capolongo, L

    1. Influence of structural modifications at the 3' and 4' positions of doxorubicin on the drug ability to trap topoisomerase II and to overcome multidrug resistance.
      G Capranico, R Supino, M Binaschi, L Capolongo, M Grandi, A Suarato and F Zunino
      Molecular Pharmacology May 1994, 45 (5) 908-915;

  2. Capranico, G

    1. Influence of structural modifications at the 3' and 4' positions of doxorubicin on the drug ability to trap topoisomerase II and to overcome multidrug resistance.
      G Capranico, R Supino, M Binaschi, L Capolongo, M Grandi, A Suarato and F Zunino
      Molecular Pharmacology May 1994, 45 (5) 908-915;

  3. Catt, K J

    1. Control of calcium spiking frequency in pituitary gonadotrophs by a single-pool cytoplasmic oscillator.
      S S Stojilkovic, M Tomic, M Kukuljan and K J Catt
      Molecular Pharmacology May 1994, 45 (5) 1013-1021;

  4. Chen, Y

    1. 5-Hydroxytryptamine type 2A receptors regulate cyclic AMP accumulation in a neuronal cell line by protein kinase C-dependent and calcium/calmodulin-dependent mechanisms.
      K A Berg, W P Clarke, Y Chen, B J Ebersole, R D McKay and S Maayani
      Molecular Pharmacology May 1994, 45 (5) 826-836;

  5. Chidester, D

    1. Biodistribution and metabolism of internally 3H-labeled oligonucleotides. I. Comparison of a phosphodiester and a phosphorothioate.
      H Sands, L J Gorey-Feret, A J Cocuzza, F W Hobbs, D Chidester and G L Trainor
      Molecular Pharmacology May 1994, 45 (5) 932-943;

  6. Ciccarelli, E

    1. Properties and regulation of the coupling to adenylate cyclase of secretin receptors stably transfected in Chinese hamster ovary cells.
      J P Vilardaga, E Ciccarelli, C Dubeaux, P De Neef, A Bollen and P Robberecht
      Molecular Pharmacology May 1994, 45 (5) 1022-1028;

  7. Clarke, W P

    1. 5-Hydroxytryptamine type 2A receptors regulate cyclic AMP accumulation in a neuronal cell line by protein kinase C-dependent and calcium/calmodulin-dependent mechanisms.
      K A Berg, W P Clarke, Y Chen, B J Ebersole, R D McKay and S Maayani
      Molecular Pharmacology May 1994, 45 (5) 826-836;

  8. Cocuzza, A J

    1. Biodistribution and metabolism of internally 3H-labeled oligonucleotides. I. Comparison of a phosphodiester and a phosphorothioate.
      H Sands, L J Gorey-Feret, A J Cocuzza, F W Hobbs, D Chidester and G L Trainor
      Molecular Pharmacology May 1994, 45 (5) 932-943;

  9. Costa, E

    1. Intracellular sodium concentration in cultured cerebellar granule cells challenged with glutamate.
      L Kiedrowski, J T Wroblewski and E Costa
      Molecular Pharmacology May 1994, 45 (5) 1050-1054;

D

  1. Davis, E M

    1. Alternative splicing of human inwardly rectifying K+ channel ROMK1 mRNA.
      H Yano, L H Philipson, J L Kugler, Y Tokuyama, E M Davis, M M Le Beau, D J Nelson, G I Bell and J Takeda
      Molecular Pharmacology May 1994, 45 (5) 854-860;

  2. De Neef, P

    1. Properties and regulation of the coupling to adenylate cyclase of secretin receptors stably transfected in Chinese hamster ovary cells.
      J P Vilardaga, E Ciccarelli, C Dubeaux, P De Neef, A Bollen and P Robberecht
      Molecular Pharmacology May 1994, 45 (5) 1022-1028;

  3. Dias, P

    1. Cross-resistance to antitumor diarylsulfonylureas and collateral sensitivity to mitochondrial toxins in a human cell line selected for resistance to the antitumor agent N-(5-indanylsulfonyl)-N'-(4-chlorophenyl)urea.
      J Sosinski, J H Thakar, G S Germain, P Dias, F C Harwood, J F Kuttesch and P J Houghton
      Molecular Pharmacology May 1994, 45 (5) 962-970;

  4. Dildy-Mayfield, J E

    1. Ethanol inhibits the function of 5-hydroxytryptamine type 1c and muscarinic M1 G protein-linked receptors in Xenopus oocytes expressing brain mRNA: role of protein kinase C.
      E Sanna, J E Dildy-Mayfield and R A Harris
      Molecular Pharmacology May 1994, 45 (5) 1004-1012;

  5. Doi, M

    1. Reinforcement effect of histamine on the differentiation of murine myeloblasts and promyelocytes: externalization of granulocyte colony-stimulating factor receptors induced by histamine.
      K Tasaka, M Doi, N Nakaya and M Mio
      Molecular Pharmacology May 1994, 45 (5) 837-845;

  6. Dolci, W

    1. Signal transduction by the cloned glucagon-like peptide-1 receptor: comparison with signaling by the endogenous receptors of beta cell lines.
      C Widmann, E Bürki, W Dolci and B Thorens
      Molecular Pharmacology May 1994, 45 (5) 1029-1035;

  7. Drapeau, P

    1. Block of the rat brain IIA sodium channel alpha subunit by the neuroprotective drug riluzole.
      T Hebert, P Drapeau, L Pradier and R J Dunn
      Molecular Pharmacology May 1994, 45 (5) 1055-1060;

  8. Dubeaux, C

    1. Properties and regulation of the coupling to adenylate cyclase of secretin receptors stably transfected in Chinese hamster ovary cells.
      J P Vilardaga, E Ciccarelli, C Dubeaux, P De Neef, A Bollen and P Robberecht
      Molecular Pharmacology May 1994, 45 (5) 1022-1028;

  9. Dunn, R J

    1. Block of the rat brain IIA sodium channel alpha subunit by the neuroprotective drug riluzole.
      T Hebert, P Drapeau, L Pradier and R J Dunn
      Molecular Pharmacology May 1994, 45 (5) 1055-1060;

E

  1. Ebersole, B J

    1. 5-Hydroxytryptamine type 2A receptors regulate cyclic AMP accumulation in a neuronal cell line by protein kinase C-dependent and calcium/calmodulin-dependent mechanisms.
      K A Berg, W P Clarke, Y Chen, B J Ebersole, R D McKay and S Maayani
      Molecular Pharmacology May 1994, 45 (5) 826-836;

  2. Eck, M

    1. Role of acidic amino acids in the allosteric modulation by gallamine of antagonist binding at the m2 muscarinic acetylcholine receptor.
      R A Leppik, R C Miller, M Eck and J L Paquet
      Molecular Pharmacology May 1994, 45 (5) 983-990;

  3. Evans, J F

    1. Protein kinase C-dependent regulation of sulfidopeptide leukotriene biosynthesis and leukotriene C4 synthase in neutrophilic HL-60 cells.
      S Kargman, A Ali, J P Vaillancourt, J F Evans and D W Nicholson
      Molecular Pharmacology May 1994, 45 (5) 1043-1049;

F

  1. Figala, V

    1. Inhibition of NADPH-oxidase activity in human polymorphonuclear neutrophils by lipophilic ascorbic acid derivatives.
      E Schmid, V Figala and V Ullrich
      Molecular Pharmacology May 1994, 45 (5) 815-825;

G

  1. Gallo-Rodriguez, C

    1. 125I-4-aminobenzyl-5'-N-methylcarboxamidoadenosine, a high affinity radioligand for the rat A3 adenosine receptor.
      M E Olah, C Gallo-Rodriguez, K A Jacobson and G L Stiles
      Molecular Pharmacology May 1994, 45 (5) 978-982;

  2. Germain, G S

    1. Cross-resistance to antitumor diarylsulfonylureas and collateral sensitivity to mitochondrial toxins in a human cell line selected for resistance to the antitumor agent N-(5-indanylsulfonyl)-N'-(4-chlorophenyl)urea.
      J Sosinski, J H Thakar, G S Germain, P Dias, F C Harwood, J F Kuttesch and P J Houghton
      Molecular Pharmacology May 1994, 45 (5) 962-970;

  3. Gorey-Feret, L J

    1. Biodistribution and metabolism of internally 3H-labeled oligonucleotides. I. Comparison of a phosphodiester and a phosphorothioate.
      H Sands, L J Gorey-Feret, A J Cocuzza, F W Hobbs, D Chidester and G L Trainor
      Molecular Pharmacology May 1994, 45 (5) 932-943;

  4. Grandi, M

    1. Influence of structural modifications at the 3' and 4' positions of doxorubicin on the drug ability to trap topoisomerase II and to overcome multidrug resistance.
      G Capranico, R Supino, M Binaschi, L Capolongo, M Grandi, A Suarato and F Zunino
      Molecular Pharmacology May 1994, 45 (5) 908-915;

  5. Grippo, P

    1. Template 2-chloro-2'-deoxyadenosine monophosphate inhibits in vitro DNA synthesis.
      P Hentosh and P Grippo
      Molecular Pharmacology May 1994, 45 (5) 955-961;

H

  1. Haddad, E B

    1. Characterization of [3H]Ba 679 BR, a slowly dissociating muscarinic antagonist, in human lung: radioligand binding and autoradiographic mapping.
      E B Haddad, J C Mak and P J Barnes
      Molecular Pharmacology May 1994, 45 (5) 899-907;

  2. Harris, R A

    1. Ethanol inhibits the function of 5-hydroxytryptamine type 1c and muscarinic M1 G protein-linked receptors in Xenopus oocytes expressing brain mRNA: role of protein kinase C.
      E Sanna, J E Dildy-Mayfield and R A Harris
      Molecular Pharmacology May 1994, 45 (5) 1004-1012;

  3. Harwood, F C

    1. Cross-resistance to antitumor diarylsulfonylureas and collateral sensitivity to mitochondrial toxins in a human cell line selected for resistance to the antitumor agent N-(5-indanylsulfonyl)-N'-(4-chlorophenyl)urea.
      J Sosinski, J H Thakar, G S Germain, P Dias, F C Harwood, J F Kuttesch and P J Houghton
      Molecular Pharmacology May 1994, 45 (5) 962-970;

  4. Hebert, T

    1. Block of the rat brain IIA sodium channel alpha subunit by the neuroprotective drug riluzole.
      T Hebert, P Drapeau, L Pradier and R J Dunn
      Molecular Pharmacology May 1994, 45 (5) 1055-1060;

  5. Hentosh, P

    1. Template 2-chloro-2'-deoxyadenosine monophosphate inhibits in vitro DNA synthesis.
      P Hentosh and P Grippo
      Molecular Pharmacology May 1994, 45 (5) 955-961;

  6. Hobbs, F W

    1. Biodistribution and metabolism of internally 3H-labeled oligonucleotides. I. Comparison of a phosphodiester and a phosphorothioate.
      H Sands, L J Gorey-Feret, A J Cocuzza, F W Hobbs, D Chidester and G L Trainor
      Molecular Pharmacology May 1994, 45 (5) 932-943;

  7. Homann, D

    1. Transfected muscarinic acetylcholine receptors selectively couple to Gi-type G proteins and Gq/11.
      S Offermanns, T Wieland, D Homann, J Sandmann, E Bombien, K Spicher, G Schultz and K H Jakobs
      Molecular Pharmacology May 1994, 45 (5) 890-898;

  8. Hong, N J

    1. Short and long term effects of cytoskeleton-disrupting drugs on cytochrome P450 Cyp1a-1 induction in murine hepatoma 1c1c7 cells: suppression by the microtubule inhibitor nocodazole.
      A Schöller, N J Hong, P Bischer and J J Reiners
      Molecular Pharmacology May 1994, 45 (5) 944-954;

  9. Houghton, P J

    1. Cross-resistance to antitumor diarylsulfonylureas and collateral sensitivity to mitochondrial toxins in a human cell line selected for resistance to the antitumor agent N-(5-indanylsulfonyl)-N'-(4-chlorophenyl)urea.
      J Sosinski, J H Thakar, G S Germain, P Dias, F C Harwood, J F Kuttesch and P J Houghton
      Molecular Pharmacology May 1994, 45 (5) 962-970;

J

  1. Jacobson, K A

    1. 125I-4-aminobenzyl-5'-N-methylcarboxamidoadenosine, a high affinity radioligand for the rat A3 adenosine receptor.
      M E Olah, C Gallo-Rodriguez, K A Jacobson and G L Stiles
      Molecular Pharmacology May 1994, 45 (5) 978-982;

  2. Jacquemin-Sablon, A

    1. Effects of tyrphostins on the activated c-src protein in NIH/3T3 cells.
      W K Agbotounou, A Levitzki, A Jacquemin-Sablon and J Pierre
      Molecular Pharmacology May 1994, 45 (5) 922-931;

  3. Jakobs, K H

    1. Transfected muscarinic acetylcholine receptors selectively couple to Gi-type G proteins and Gq/11.
      S Offermanns, T Wieland, D Homann, J Sandmann, E Bombien, K Spicher, G Schultz and K H Jakobs
      Molecular Pharmacology May 1994, 45 (5) 890-898;

K

  1. Kargman, S

    1. Protein kinase C-dependent regulation of sulfidopeptide leukotriene biosynthesis and leukotriene C4 synthase in neutrophilic HL-60 cells.
      S Kargman, A Ali, J P Vaillancourt, J F Evans and D W Nicholson
      Molecular Pharmacology May 1994, 45 (5) 1043-1049;

  2. Kiedrowski, L

    1. Intracellular sodium concentration in cultured cerebellar granule cells challenged with glutamate.
      L Kiedrowski, J T Wroblewski and E Costa
      Molecular Pharmacology May 1994, 45 (5) 1050-1054;

  3. Kondo, Y

    1. A single species of A1 adenosine receptor expressed in Chinese hamster ovary cells not only inhibits cAMP accumulation but also stimulates phospholipase C and arachidonate release.
      M Akbar, F Okajima, H Tomura, S Shimegi and Y Kondo
      Molecular Pharmacology May 1994, 45 (5) 1036-1042;

  4. Korpi, E R

    1. Impact of beta and gamma variants on ligand-binding properties of gamma-aminobutyric acid type A receptors.
      H Lüddens, P H Seeburg and E R Korpi
      Molecular Pharmacology May 1994, 45 (5) 810-814;

  5. Kugler, J L

    1. Alternative splicing of human inwardly rectifying K+ channel ROMK1 mRNA.
      H Yano, L H Philipson, J L Kugler, Y Tokuyama, E M Davis, M M Le Beau, D J Nelson, G I Bell and J Takeda
      Molecular Pharmacology May 1994, 45 (5) 854-860;

  6. Kuiper, J

    1. Activation of rat Kupffer cells to tumoricidal cells by the immunomodulator muramyl tripeptide-phosphatidylethanolamine incorporated into the novel drug carrier lactosylated low density lipoprotein.
      B van de Water, T J van Berkel and J Kuiper
      Molecular Pharmacology May 1994, 45 (5) 971-977;

  7. Kukuljan, M

    1. Control of calcium spiking frequency in pituitary gonadotrophs by a single-pool cytoplasmic oscillator.
      S S Stojilkovic, M Tomic, M Kukuljan and K J Catt
      Molecular Pharmacology May 1994, 45 (5) 1013-1021;

  8. Kuttesch, J F

    1. Cross-resistance to antitumor diarylsulfonylureas and collateral sensitivity to mitochondrial toxins in a human cell line selected for resistance to the antitumor agent N-(5-indanylsulfonyl)-N'-(4-chlorophenyl)urea.
      J Sosinski, J H Thakar, G S Germain, P Dias, F C Harwood, J F Kuttesch and P J Houghton
      Molecular Pharmacology May 1994, 45 (5) 962-970;

L

  1. Lachowicz, J E

    1. The D2S and D2L dopamine receptor isoforms are differentially regulated in Chinese hamster ovary cells.
      L J Zhang, J E Lachowicz and D R Sibley
      Molecular Pharmacology May 1994, 45 (5) 878-889;

  2. Law, P Y

    1. Interaction of delta-opioid receptors with multiple G proteins: a non-relationship between agonist potency to inhibit adenylyl cyclase and to activate G proteins.
      P L Prather, H H Loh and P Y Law
      Molecular Pharmacology May 1994, 45 (5) 997-1003;

  3. Le Beau, M M

    1. Alternative splicing of human inwardly rectifying K+ channel ROMK1 mRNA.
      H Yano, L H Philipson, J L Kugler, Y Tokuyama, E M Davis, M M Le Beau, D J Nelson, G I Bell and J Takeda
      Molecular Pharmacology May 1994, 45 (5) 854-860;

  4. Leppik, R A

    1. Role of acidic amino acids in the allosteric modulation by gallamine of antagonist binding at the m2 muscarinic acetylcholine receptor.
      R A Leppik, R C Miller, M Eck and J L Paquet
      Molecular Pharmacology May 1994, 45 (5) 983-990;

  5. Levitzki, A

    1. Effects of tyrphostins on the activated c-src protein in NIH/3T3 cells.
      W K Agbotounou, A Levitzki, A Jacquemin-Sablon and J Pierre
      Molecular Pharmacology May 1994, 45 (5) 922-931;

  6. Loh, H H

    1. Interaction of delta-opioid receptors with multiple G proteins: a non-relationship between agonist potency to inhibit adenylyl cyclase and to activate G proteins.
      P L Prather, H H Loh and P Y Law
      Molecular Pharmacology May 1994, 45 (5) 997-1003;

  7. Lüddens, H

    1. Impact of beta and gamma variants on ligand-binding properties of gamma-aminobutyric acid type A receptors.
      H Lüddens, P H Seeburg and E R Korpi
      Molecular Pharmacology May 1994, 45 (5) 810-814;

M

  1. Maayani, S

    1. 5-Hydroxytryptamine type 2A receptors regulate cyclic AMP accumulation in a neuronal cell line by protein kinase C-dependent and calcium/calmodulin-dependent mechanisms.
      K A Berg, W P Clarke, Y Chen, B J Ebersole, R D McKay and S Maayani
      Molecular Pharmacology May 1994, 45 (5) 826-836;

  2. Mak, J C

    1. Characterization of [3H]Ba 679 BR, a slowly dissociating muscarinic antagonist, in human lung: radioligand binding and autoradiographic mapping.
      E B Haddad, J C Mak and P J Barnes
      Molecular Pharmacology May 1994, 45 (5) 899-907;

  3. Mayer, S E

    1. 5-Hydroxytryptamine type 2A and 2C receptors linked to Na+/K+/Cl- cotransport.
      S E Mayer and E Sanders-Bush
      Molecular Pharmacology May 1994, 45 (5) 991-996;

  4. McKay, R D

    1. 5-Hydroxytryptamine type 2A receptors regulate cyclic AMP accumulation in a neuronal cell line by protein kinase C-dependent and calcium/calmodulin-dependent mechanisms.
      K A Berg, W P Clarke, Y Chen, B J Ebersole, R D McKay and S Maayani
      Molecular Pharmacology May 1994, 45 (5) 826-836;

  5. Miller, R C

    1. Role of acidic amino acids in the allosteric modulation by gallamine of antagonist binding at the m2 muscarinic acetylcholine receptor.
      R A Leppik, R C Miller, M Eck and J L Paquet
      Molecular Pharmacology May 1994, 45 (5) 983-990;

  6. Mio, M

    1. Reinforcement effect of histamine on the differentiation of murine myeloblasts and promyelocytes: externalization of granulocyte colony-stimulating factor receptors induced by histamine.
      K Tasaka, M Doi, N Nakaya and M Mio
      Molecular Pharmacology May 1994, 45 (5) 837-845;

  7. Molinoff, P B

    1. Sensitivity of the N-methyl-D-aspartate receptor to polyamines is controlled by NR2 subunits.
      K Williams, A M Zappia, D B Pritchett, Y M Shen and P B Molinoff
      Molecular Pharmacology May 1994, 45 (5) 803-809;
    2. Expression of mRNAs encoding subunits of the N-methyl-D-aspartate receptor in cultured cortical neurons.
      J Zhong, S L Russell, D B Pritchett, P B Molinoff and K Williams
      Molecular Pharmacology May 1994, 45 (5) 846-853;

N

  1. Nakaya, N

    1. Reinforcement effect of histamine on the differentiation of murine myeloblasts and promyelocytes: externalization of granulocyte colony-stimulating factor receptors induced by histamine.
      K Tasaka, M Doi, N Nakaya and M Mio
      Molecular Pharmacology May 1994, 45 (5) 837-845;

  2. Nelson, D J

    1. Alternative splicing of human inwardly rectifying K+ channel ROMK1 mRNA.
      H Yano, L H Philipson, J L Kugler, Y Tokuyama, E M Davis, M M Le Beau, D J Nelson, G I Bell and J Takeda
      Molecular Pharmacology May 1994, 45 (5) 854-860;

  3. Nicholson, D W

    1. Protein kinase C-dependent regulation of sulfidopeptide leukotriene biosynthesis and leukotriene C4 synthase in neutrophilic HL-60 cells.
      S Kargman, A Ali, J P Vaillancourt, J F Evans and D W Nicholson
      Molecular Pharmacology May 1994, 45 (5) 1043-1049;

O

  1. Offermanns, S

    1. Transfected muscarinic acetylcholine receptors selectively couple to Gi-type G proteins and Gq/11.
      S Offermanns, T Wieland, D Homann, J Sandmann, E Bombien, K Spicher, G Schultz and K H Jakobs
      Molecular Pharmacology May 1994, 45 (5) 890-898;

  2. Okajima, F

    1. A single species of A1 adenosine receptor expressed in Chinese hamster ovary cells not only inhibits cAMP accumulation but also stimulates phospholipase C and arachidonate release.
      M Akbar, F Okajima, H Tomura, S Shimegi and Y Kondo
      Molecular Pharmacology May 1994, 45 (5) 1036-1042;

  3. Olah, M E

    1. 125I-4-aminobenzyl-5'-N-methylcarboxamidoadenosine, a high affinity radioligand for the rat A3 adenosine receptor.
      M E Olah, C Gallo-Rodriguez, K A Jacobson and G L Stiles
      Molecular Pharmacology May 1994, 45 (5) 978-982;

P

  1. Paquet, J L

    1. Role of acidic amino acids in the allosteric modulation by gallamine of antagonist binding at the m2 muscarinic acetylcholine receptor.
      R A Leppik, R C Miller, M Eck and J L Paquet
      Molecular Pharmacology May 1994, 45 (5) 983-990;

  2. Philipson, L H

    1. Alternative splicing of human inwardly rectifying K+ channel ROMK1 mRNA.
      H Yano, L H Philipson, J L Kugler, Y Tokuyama, E M Davis, M M Le Beau, D J Nelson, G I Bell and J Takeda
      Molecular Pharmacology May 1994, 45 (5) 854-860;

  3. Pierre, J

    1. Effects of tyrphostins on the activated c-src protein in NIH/3T3 cells.
      W K Agbotounou, A Levitzki, A Jacquemin-Sablon and J Pierre
      Molecular Pharmacology May 1994, 45 (5) 922-931;

  4. Piersen, C E

    1. A carboxyl-terminally truncated mutant and nonglycosylated A2a adenosine receptors retain ligand binding.
      C E Piersen, C D True and J N Wells
      Molecular Pharmacology May 1994, 45 (5) 861-870;
    2. 125I-2-[4-[2-[2-[(4-azidophenyl)methylcarbonylamino] ethylaminocarbonyl]ethyl]phenyl] ethylamino-5'-N-ethylcarboxamidoadenosine labels transmembrane span V of the A2a adenosine receptor.
      C E Piersen, C D True and J N Wells
      Molecular Pharmacology May 1994, 45 (5) 871-877;

  5. Polsky, B

    1. Elevation of glutathione levels by phase II enzyme inducers: lack of inhibition of human immunodeficiency virus type 1 replication in chronically infected monocytoid cells.
      H J Prochaska, L Rubinson, Y Yeh, P Baron and B Polsky
      Molecular Pharmacology May 1994, 45 (5) 916-921;

  6. Pradier, L

    1. Block of the rat brain IIA sodium channel alpha subunit by the neuroprotective drug riluzole.
      T Hebert, P Drapeau, L Pradier and R J Dunn
      Molecular Pharmacology May 1994, 45 (5) 1055-1060;

  7. Prather, P L

    1. Interaction of delta-opioid receptors with multiple G proteins: a non-relationship between agonist potency to inhibit adenylyl cyclase and to activate G proteins.
      P L Prather, H H Loh and P Y Law
      Molecular Pharmacology May 1994, 45 (5) 997-1003;

  8. Pritchett, D B

    1. Sensitivity of the N-methyl-D-aspartate receptor to polyamines is controlled by NR2 subunits.
      K Williams, A M Zappia, D B Pritchett, Y M Shen and P B Molinoff
      Molecular Pharmacology May 1994, 45 (5) 803-809;
    2. Expression of mRNAs encoding subunits of the N-methyl-D-aspartate receptor in cultured cortical neurons.
      J Zhong, S L Russell, D B Pritchett, P B Molinoff and K Williams
      Molecular Pharmacology May 1994, 45 (5) 846-853;

  9. Prochaska, H J

    1. Elevation of glutathione levels by phase II enzyme inducers: lack of inhibition of human immunodeficiency virus type 1 replication in chronically infected monocytoid cells.
      H J Prochaska, L Rubinson, Y Yeh, P Baron and B Polsky
      Molecular Pharmacology May 1994, 45 (5) 916-921;

R

  1. Reiners, J J

    1. Short and long term effects of cytoskeleton-disrupting drugs on cytochrome P450 Cyp1a-1 induction in murine hepatoma 1c1c7 cells: suppression by the microtubule inhibitor nocodazole.
      A Schöller, N J Hong, P Bischer and J J Reiners
      Molecular Pharmacology May 1994, 45 (5) 944-954;

  2. Robberecht, P

    1. Properties and regulation of the coupling to adenylate cyclase of secretin receptors stably transfected in Chinese hamster ovary cells.
      J P Vilardaga, E Ciccarelli, C Dubeaux, P De Neef, A Bollen and P Robberecht
      Molecular Pharmacology May 1994, 45 (5) 1022-1028;

  3. Rubinson, L

    1. Elevation of glutathione levels by phase II enzyme inducers: lack of inhibition of human immunodeficiency virus type 1 replication in chronically infected monocytoid cells.
      H J Prochaska, L Rubinson, Y Yeh, P Baron and B Polsky
      Molecular Pharmacology May 1994, 45 (5) 916-921;

  4. Russell, S L

    1. Expression of mRNAs encoding subunits of the N-methyl-D-aspartate receptor in cultured cortical neurons.
      J Zhong, S L Russell, D B Pritchett, P B Molinoff and K Williams
      Molecular Pharmacology May 1994, 45 (5) 846-853;

S

  1. Sanders-Bush, E

    1. 5-Hydroxytryptamine type 2A and 2C receptors linked to Na+/K+/Cl- cotransport.
      S E Mayer and E Sanders-Bush
      Molecular Pharmacology May 1994, 45 (5) 991-996;

  2. Sandmann, J

    1. Transfected muscarinic acetylcholine receptors selectively couple to Gi-type G proteins and Gq/11.
      S Offermanns, T Wieland, D Homann, J Sandmann, E Bombien, K Spicher, G Schultz and K H Jakobs
      Molecular Pharmacology May 1994, 45 (5) 890-898;

  3. Sands, H

    1. Biodistribution and metabolism of internally 3H-labeled oligonucleotides. I. Comparison of a phosphodiester and a phosphorothioate.
      H Sands, L J Gorey-Feret, A J Cocuzza, F W Hobbs, D Chidester and G L Trainor
      Molecular Pharmacology May 1994, 45 (5) 932-943;

  4. Sanna, E

    1. Ethanol inhibits the function of 5-hydroxytryptamine type 1c and muscarinic M1 G protein-linked receptors in Xenopus oocytes expressing brain mRNA: role of protein kinase C.
      E Sanna, J E Dildy-Mayfield and R A Harris
      Molecular Pharmacology May 1994, 45 (5) 1004-1012;

  5. Schmid, E

    1. Inhibition of NADPH-oxidase activity in human polymorphonuclear neutrophils by lipophilic ascorbic acid derivatives.
      E Schmid, V Figala and V Ullrich
      Molecular Pharmacology May 1994, 45 (5) 815-825;

  6. Schöller, A

    1. Short and long term effects of cytoskeleton-disrupting drugs on cytochrome P450 Cyp1a-1 induction in murine hepatoma 1c1c7 cells: suppression by the microtubule inhibitor nocodazole.
      A Schöller, N J Hong, P Bischer and J J Reiners
      Molecular Pharmacology May 1994, 45 (5) 944-954;

  7. Schultz, G

    1. Transfected muscarinic acetylcholine receptors selectively couple to Gi-type G proteins and Gq/11.
      S Offermanns, T Wieland, D Homann, J Sandmann, E Bombien, K Spicher, G Schultz and K H Jakobs
      Molecular Pharmacology May 1994, 45 (5) 890-898;

  8. Seeburg, P H

    1. Impact of beta and gamma variants on ligand-binding properties of gamma-aminobutyric acid type A receptors.
      H Lüddens, P H Seeburg and E R Korpi
      Molecular Pharmacology May 1994, 45 (5) 810-814;

  9. Shen, Y M

    1. Sensitivity of the N-methyl-D-aspartate receptor to polyamines is controlled by NR2 subunits.
      K Williams, A M Zappia, D B Pritchett, Y M Shen and P B Molinoff
      Molecular Pharmacology May 1994, 45 (5) 803-809;

  10. Shimegi, S

    1. A single species of A1 adenosine receptor expressed in Chinese hamster ovary cells not only inhibits cAMP accumulation but also stimulates phospholipase C and arachidonate release.
      M Akbar, F Okajima, H Tomura, S Shimegi and Y Kondo
      Molecular Pharmacology May 1994, 45 (5) 1036-1042;

  11. Sibley, D R

    1. The D2S and D2L dopamine receptor isoforms are differentially regulated in Chinese hamster ovary cells.
      L J Zhang, J E Lachowicz and D R Sibley
      Molecular Pharmacology May 1994, 45 (5) 878-889;

  12. Sosinski, J

    1. Cross-resistance to antitumor diarylsulfonylureas and collateral sensitivity to mitochondrial toxins in a human cell line selected for resistance to the antitumor agent N-(5-indanylsulfonyl)-N'-(4-chlorophenyl)urea.
      J Sosinski, J H Thakar, G S Germain, P Dias, F C Harwood, J F Kuttesch and P J Houghton
      Molecular Pharmacology May 1994, 45 (5) 962-970;

  13. Spicher, K

    1. Transfected muscarinic acetylcholine receptors selectively couple to Gi-type G proteins and Gq/11.
      S Offermanns, T Wieland, D Homann, J Sandmann, E Bombien, K Spicher, G Schultz and K H Jakobs
      Molecular Pharmacology May 1994, 45 (5) 890-898;

  14. Stiles, G L

    1. 125I-4-aminobenzyl-5'-N-methylcarboxamidoadenosine, a high affinity radioligand for the rat A3 adenosine receptor.
      M E Olah, C Gallo-Rodriguez, K A Jacobson and G L Stiles
      Molecular Pharmacology May 1994, 45 (5) 978-982;

  15. Stojilkovic, S S

    1. Control of calcium spiking frequency in pituitary gonadotrophs by a single-pool cytoplasmic oscillator.
      S S Stojilkovic, M Tomic, M Kukuljan and K J Catt
      Molecular Pharmacology May 1994, 45 (5) 1013-1021;

  16. Suarato, A

    1. Influence of structural modifications at the 3' and 4' positions of doxorubicin on the drug ability to trap topoisomerase II and to overcome multidrug resistance.
      G Capranico, R Supino, M Binaschi, L Capolongo, M Grandi, A Suarato and F Zunino
      Molecular Pharmacology May 1994, 45 (5) 908-915;

  17. Supino, R

    1. Influence of structural modifications at the 3' and 4' positions of doxorubicin on the drug ability to trap topoisomerase II and to overcome multidrug resistance.
      G Capranico, R Supino, M Binaschi, L Capolongo, M Grandi, A Suarato and F Zunino
      Molecular Pharmacology May 1994, 45 (5) 908-915;

T

  1. Takeda, J

    1. Alternative splicing of human inwardly rectifying K+ channel ROMK1 mRNA.
      H Yano, L H Philipson, J L Kugler, Y Tokuyama, E M Davis, M M Le Beau, D J Nelson, G I Bell and J Takeda
      Molecular Pharmacology May 1994, 45 (5) 854-860;

  2. Tasaka, K

    1. Reinforcement effect of histamine on the differentiation of murine myeloblasts and promyelocytes: externalization of granulocyte colony-stimulating factor receptors induced by histamine.
      K Tasaka, M Doi, N Nakaya and M Mio
      Molecular Pharmacology May 1994, 45 (5) 837-845;

  3. Thakar, J H

    1. Cross-resistance to antitumor diarylsulfonylureas and collateral sensitivity to mitochondrial toxins in a human cell line selected for resistance to the antitumor agent N-(5-indanylsulfonyl)-N'-(4-chlorophenyl)urea.
      J Sosinski, J H Thakar, G S Germain, P Dias, F C Harwood, J F Kuttesch and P J Houghton
      Molecular Pharmacology May 1994, 45 (5) 962-970;

  4. Thorens, B

    1. Signal transduction by the cloned glucagon-like peptide-1 receptor: comparison with signaling by the endogenous receptors of beta cell lines.
      C Widmann, E Bürki, W Dolci and B Thorens
      Molecular Pharmacology May 1994, 45 (5) 1029-1035;

  5. Tokuyama, Y

    1. Alternative splicing of human inwardly rectifying K+ channel ROMK1 mRNA.
      H Yano, L H Philipson, J L Kugler, Y Tokuyama, E M Davis, M M Le Beau, D J Nelson, G I Bell and J Takeda
      Molecular Pharmacology May 1994, 45 (5) 854-860;

  6. Tomic, M

    1. Control of calcium spiking frequency in pituitary gonadotrophs by a single-pool cytoplasmic oscillator.
      S S Stojilkovic, M Tomic, M Kukuljan and K J Catt
      Molecular Pharmacology May 1994, 45 (5) 1013-1021;

  7. Tomura, H

    1. A single species of A1 adenosine receptor expressed in Chinese hamster ovary cells not only inhibits cAMP accumulation but also stimulates phospholipase C and arachidonate release.
      M Akbar, F Okajima, H Tomura, S Shimegi and Y Kondo
      Molecular Pharmacology May 1994, 45 (5) 1036-1042;

  8. Trainor, G L

    1. Biodistribution and metabolism of internally 3H-labeled oligonucleotides. I. Comparison of a phosphodiester and a phosphorothioate.
      H Sands, L J Gorey-Feret, A J Cocuzza, F W Hobbs, D Chidester and G L Trainor
      Molecular Pharmacology May 1994, 45 (5) 932-943;

  9. True, C D

    1. A carboxyl-terminally truncated mutant and nonglycosylated A2a adenosine receptors retain ligand binding.
      C E Piersen, C D True and J N Wells
      Molecular Pharmacology May 1994, 45 (5) 861-870;
    2. 125I-2-[4-[2-[2-[(4-azidophenyl)methylcarbonylamino] ethylaminocarbonyl]ethyl]phenyl] ethylamino-5'-N-ethylcarboxamidoadenosine labels transmembrane span V of the A2a adenosine receptor.
      C E Piersen, C D True and J N Wells
      Molecular Pharmacology May 1994, 45 (5) 871-877;

U

  1. Ullrich, V

    1. Inhibition of NADPH-oxidase activity in human polymorphonuclear neutrophils by lipophilic ascorbic acid derivatives.
      E Schmid, V Figala and V Ullrich
      Molecular Pharmacology May 1994, 45 (5) 815-825;

V

  1. Vaillancourt, J P

    1. Protein kinase C-dependent regulation of sulfidopeptide leukotriene biosynthesis and leukotriene C4 synthase in neutrophilic HL-60 cells.
      S Kargman, A Ali, J P Vaillancourt, J F Evans and D W Nicholson
      Molecular Pharmacology May 1994, 45 (5) 1043-1049;

  2. van Berkel, T J

    1. Activation of rat Kupffer cells to tumoricidal cells by the immunomodulator muramyl tripeptide-phosphatidylethanolamine incorporated into the novel drug carrier lactosylated low density lipoprotein.
      B van de Water, T J van Berkel and J Kuiper
      Molecular Pharmacology May 1994, 45 (5) 971-977;

  3. van de Water, B

    1. Activation of rat Kupffer cells to tumoricidal cells by the immunomodulator muramyl tripeptide-phosphatidylethanolamine incorporated into the novel drug carrier lactosylated low density lipoprotein.
      B van de Water, T J van Berkel and J Kuiper
      Molecular Pharmacology May 1994, 45 (5) 971-977;

  4. Vilardaga, J P

    1. Properties and regulation of the coupling to adenylate cyclase of secretin receptors stably transfected in Chinese hamster ovary cells.
      J P Vilardaga, E Ciccarelli, C Dubeaux, P De Neef, A Bollen and P Robberecht
      Molecular Pharmacology May 1994, 45 (5) 1022-1028;

W

  1. Wells, J N

    1. A carboxyl-terminally truncated mutant and nonglycosylated A2a adenosine receptors retain ligand binding.
      C E Piersen, C D True and J N Wells
      Molecular Pharmacology May 1994, 45 (5) 861-870;
    2. 125I-2-[4-[2-[2-[(4-azidophenyl)methylcarbonylamino] ethylaminocarbonyl]ethyl]phenyl] ethylamino-5'-N-ethylcarboxamidoadenosine labels transmembrane span V of the A2a adenosine receptor.
      C E Piersen, C D True and J N Wells
      Molecular Pharmacology May 1994, 45 (5) 871-877;

  2. Widmann, C

    1. Signal transduction by the cloned glucagon-like peptide-1 receptor: comparison with signaling by the endogenous receptors of beta cell lines.
      C Widmann, E Bürki, W Dolci and B Thorens
      Molecular Pharmacology May 1994, 45 (5) 1029-1035;

  3. Wieland, T

    1. Transfected muscarinic acetylcholine receptors selectively couple to Gi-type G proteins and Gq/11.
      S Offermanns, T Wieland, D Homann, J Sandmann, E Bombien, K Spicher, G Schultz and K H Jakobs
      Molecular Pharmacology May 1994, 45 (5) 890-898;

  4. Williams, K

    1. Sensitivity of the N-methyl-D-aspartate receptor to polyamines is controlled by NR2 subunits.
      K Williams, A M Zappia, D B Pritchett, Y M Shen and P B Molinoff
      Molecular Pharmacology May 1994, 45 (5) 803-809;
    2. Expression of mRNAs encoding subunits of the N-methyl-D-aspartate receptor in cultured cortical neurons.
      J Zhong, S L Russell, D B Pritchett, P B Molinoff and K Williams
      Molecular Pharmacology May 1994, 45 (5) 846-853;

  5. Wroblewski, J T

    1. Intracellular sodium concentration in cultured cerebellar granule cells challenged with glutamate.
      L Kiedrowski, J T Wroblewski and E Costa
      Molecular Pharmacology May 1994, 45 (5) 1050-1054;

Y

  1. Yano, H

    1. Alternative splicing of human inwardly rectifying K+ channel ROMK1 mRNA.
      H Yano, L H Philipson, J L Kugler, Y Tokuyama, E M Davis, M M Le Beau, D J Nelson, G I Bell and J Takeda
      Molecular Pharmacology May 1994, 45 (5) 854-860;

  2. Yeh, Y

    1. Elevation of glutathione levels by phase II enzyme inducers: lack of inhibition of human immunodeficiency virus type 1 replication in chronically infected monocytoid cells.
      H J Prochaska, L Rubinson, Y Yeh, P Baron and B Polsky
      Molecular Pharmacology May 1994, 45 (5) 916-921;

Z

  1. Zappia, A M

    1. Sensitivity of the N-methyl-D-aspartate receptor to polyamines is controlled by NR2 subunits.
      K Williams, A M Zappia, D B Pritchett, Y M Shen and P B Molinoff
      Molecular Pharmacology May 1994, 45 (5) 803-809;

  2. Zhang, L J

    1. The D2S and D2L dopamine receptor isoforms are differentially regulated in Chinese hamster ovary cells.
      L J Zhang, J E Lachowicz and D R Sibley
      Molecular Pharmacology May 1994, 45 (5) 878-889;

  3. Zhong, J

    1. Expression of mRNAs encoding subunits of the N-methyl-D-aspartate receptor in cultured cortical neurons.
      J Zhong, S L Russell, D B Pritchett, P B Molinoff and K Williams
      Molecular Pharmacology May 1994, 45 (5) 846-853;

  4. Zunino, F

    1. Influence of structural modifications at the 3' and 4' positions of doxorubicin on the drug ability to trap topoisomerase II and to overcome multidrug resistance.
      G Capranico, R Supino, M Binaschi, L Capolongo, M Grandi, A Suarato and F Zunino
      Molecular Pharmacology May 1994, 45 (5) 908-915;
Back to top

In this issue

Advertisement